WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005107730) CYSTEAMINES FOR TREATING COMPLICATIONS OF HYPERCHOLESTEROLEMIA AND DIABETES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/107730    International Application No.:    PCT/US2005/015306
Publication Date: 17.11.2005 International Filing Date: 29.04.2005
IPC:
A61K 31/095 (2006.01), A61P 3/06 (2006.01), A61P 3/10 (2006.01), A61P 3/00 (2006.01), A61P 43/00 (2006.01), A61P 3/04 (2006.01), A61P 5/00 (2006.01), A61K 47/48 (2006.01), A61K 51/12 (2006.01)
Applicants: OMEGA BIO-PHARMA (I.P.3) LIMITED [CN/CN]; Unit 613, 6/F, West Wing Office Building, New World Centre, 20 Salisbury Road, Tsimshatsui, Kowloon, Hong Kong (CN) (For All Designated States Except US).
CHAN, Bill, Piu [US/CN]; (CN) (For US Only).
WONG, Gary, Kwan, Po [CN/CN]; (CN) (For US Only).
XU, Jinxian [CN/CN]; (CN) (For US Only).
CHI, Francis [PT/CN]; (HK) (For US Only)
Inventors: CHAN, Bill, Piu; (CN).
WONG, Gary, Kwan, Po; (CN).
XU, Jinxian; (CN).
CHI, Francis; (HK)
Agent: EFRON, Margaret; Saliwanchik, Lloyd & Saliwanchik, A Professional Association, PO Box 142950, Gainesville, FL 32614-2950 (US)
Priority Data:
60/567,899 03.05.2004 US
60/637,618 20.12.2004 US
Title (EN) CYSTEAMINES FOR TREATING COMPLICATIONS OF HYPERCHOLESTEROLEMIA AND DIABETES
(FR) MATIERES ET PROCEDES DE MODULATION DU METABOLISME
Abstract: front page image
(EN)The subject invention provides materials and methods for modulating a variety of biological factors to treat biological conditions associated with the factors. In one embodiment of the invention, a cysteamine compound is administered to a patient to treat hypercholesterolemia and/or complications associated with hypercholesterolemia. In another embodiment, a cysteamine compound is administered to a patient to prevent the onset of diabetes in an at-risk patient and/or treat or prevent the onset of diabetes-associated complications.
(FR)Des matières et des procédés de modulation d'une grande variété de facteurs biologiques permettant de traiter des pathologies biologiques associées à ces facteurs. Dans un mode de réalisation, un composé de cystéamine est administré à un patient pour traiter l'hypercholestérolémie et/ou des complications associées à l'hypercholestérolémie. Dans un autre mode de réalisation, un composé de cystéamine est administré à un patient pour éviter l'apparition du diabète chez un patient à risque et/ou traiter ou prévenir l'apparition de complications associées au diabète.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)